Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6540617 | 1.00 | ADRB3 (0.60) | ADRB3ADRB1 | |
| Hydrochloric Acid SCHEMBL6540671 | 0.99 | ADRB3 (0.59) | ADRB3ADRB1 | |
| Hydrochloric Acid SCHEMBL6540678 | 0.99 | ADRB3 (0.59) | ADRB3ADRB1 | |
| Hydrochloric Acid SCHEMBL6540530 | 0.93 | ADRB3 (0.68) | ADRB3ADRB1 | |
| Hydrochloric Acid SCHEMBL6540535 | 0.93 | ADRB3 (0.68) | ADRB3ADRB1 | |
| SCHEMBL6539956 | 0.92 | ADRB3 (0.53) | ADRB3ADRB1 | |
| SCHEMBL6539963 | 0.92 | ADRB3 (0.53) | ADRB3ADRB1 | |
| SCHEMBL1352847 | 0.87 | ADRB3 (0.78) | ADRB3ADRB1 | |
| SCHEMBL1352848 | 0.87 | ADRB3 (0.78) | ADRB3ADRB1 | |
| SCHEMBL1352546 | 0.87 | ADRB3 (0.78) | ADRB3ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040138462-A1 | Aminoalcohol derivatives | ASTELLAS PHARMA INC. (JP) | 2004-07-15 | — | — | US | disclosed |
| EP-1389185-A2 | AMINOALCOHOL DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-02-18 | — | — | EP | disclosed |
| WO-2002094770-A2 | AMINOALCOHOL DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-11-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040138462-A1 | Aminoalcohol derivatives | BPHL, FANCD2, HRH2 | ADRB3 58/4885ADRB1 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.